Patent application number | Description | Published |
20100022926 | CHAIR - A chair with articulable support sections and an integrated lift system may have support sections mechanically linked such that a single actuation control device may articulate multiple sections. The chair includes configurable accessories directed to the comfort of an occupant of the chair. The support sections may include air cells to adjust firmness of support section surfaces. | 01-28-2010 |
20100146705 | PATIENT-SUPPORT APPARATUS WITH A LOCKING DECK SECTION - A patient-support apparatus includes a patient-support deck movable from a use position to a stowed position. The patient-support deck is configured to engage receivers of the patient-support apparatus to support the deck in a cantilevered configuration. The patient-support deck may be secured to the patient-support apparatus by a locking mechanism. A storage structure is configured to support the patient-support deck in a stowed position. The storage structure is configured to deflect under load to prevent damage to the storage structure or patient-support deck. | 06-17-2010 |
20100251484 | OVER-MOLDED LIMB SUPPORT - A limb support coupled to a patient-support apparatus comprises a frame having a pair of locks to block vertical and horizontal pivoting of the limb support in relation to the patient-support apparatus. The lock release actuator is configured to be coupled to the frame to simultaneously unlock both the vertical and horizontal rotation locks. The limb support includes a stowable leg support configured to provide support to the leg of a patient during obstetric delivery. | 10-07-2010 |
20100275375 | BIRTHING BED LIFT OFF FOOT SECTION - A patient-support apparatus includes receivers for supporting a patient-support deck. The patient-support deck is configured to engage the receivers to support the deck in a cantilevered configuration. The patient-support deck may be secured to the patient-support apparatus by a locking mechanism. | 11-04-2010 |
20110162145 | HOSPITAL BED FRAME - A bed for a person is provided. The bed includes a frame, a deck, a mattress, a pair of head end siderails, and a pair of foot end siderails. The bed further includes a controller configured to be coupled to the head and foot end siderails. | 07-07-2011 |
20110191959 | HOSPITAL BED LIFT AND BRAKING MECHANISMS - A patient support including a frame, plurality of wheels coupled to the frame, a deck, and a scissor mechanism coupled to the frame and the deck to move the deck from a raised position to a lowered position. The support includes brake mechanism including a brake pad to contact the floor to prevent the patient support from rolling. | 08-11-2011 |
20120043794 | Chair - A chair with articulable support sections and an integrated lift system may have support sections mechanically linked such that a single actuation control device may articulate multiple sections. The chair includes configurable accessories directed to the comfort of an occupant of the chair. The support sections may include air cells to adjust firmness of support section surfaces. | 02-23-2012 |
20120144585 | PATIENT-SUPPORT APPARATUS WITH A LOCKING DECK SECTION - A patient-support apparatus includes a patient-support deck movable from a use position to a stowed position. The patient-support deck is configured to engage receivers of the patient-support apparatus to support the deck in a cantilevered configuration. The patient-support deck may be secured to the patient-support apparatus by a locking mechanism. A storage structure is configured to support the patient-support deck in a stowed position. The storage structure is configured to deflect under load to prevent damage to the storage structure or patient-support deck. | 06-14-2012 |
20130099546 | CHAIR HAVING POWERED LEG EXTENSION - A chair with articulable support sections and an integrated lift system may have support sections mechanically linked such that a single actuation control device may articulate multiple sections. The chair includes configurable accessories directed to the comfort of an occupant of the chair. The support sections may include air cells to adjust firmness of support section surfaces. | 04-25-2013 |
20130104309 | BIRTHING BED LIFT OFF FOOT SECTION | 05-02-2013 |
20150224005 | HOSPITAL BED - A patient support includes a frame and a mattress supported by the frame. The frame includes a deck support and a deck supporting the mattress. | 08-13-2015 |
Patent application number | Description | Published |
20100247513 | TREATMENT OF CARPAL TUNNEL SYNDROME BY INJECTION OF THE FLEXOR RETINACULUM - An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent thereto, wherein the agent is configured to weaken the flexor retinaculum. The system may further include means for increasing the tensile stress in the flexor retinaculum post-injection using hand exercises, thereby weakening its structural integrity and decreasing the pressure within the carpal tunnel that impairs median nerve function. | 09-30-2010 |
20140193394 | TREATMENT OF CARPAL TUNNEL SYNDROME BY INJECTION OF THE FLEXOR RETINACULUM - An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent thereto, wherein the agent is configured to weaken the flexor retinaculum. The system may further include means for increasing the tensile stress in the flexor retinaculum post-injection using hand exercises, thereby weakening its structural integrity and decreasing the pressure within the carpal tunnel that impairs median nerve function. | 07-10-2014 |
20140290666 | TREATMENT OF CARPAL TUNNEL SYNDROME BY INJECTION OF THE FLEXOR RETINACULUM - An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent thereto, wherein the agent is configured to weaken the flexor retinaculum. The system may further include means for increasing the tensile stress in the flexor retinaculum post-injection using hand exercises, thereby weakening its structural integrity and decreasing the pressure within the carpal tunnel that impairs median nerve function. | 10-02-2014 |
Patent application number | Description | Published |
20120279925 | METHOD AND APPARATUS FOR TREATING NATURAL GAS AND OIL WELL DRILLING WASTE WATER - A method of treating contaminated water effluent from a well drilling operation. The method comprises decomposing organic contaminants in the effluent by bubbling a gas containing ozone through the effluent; adding a coagulant to increase the particle size of solid particles contained in the effluent; adding a flocculant to increase the particle size of solid particles contained in the effluent, thereby forming flocs suspended in the effluent; and filtering the flocs from the effluent to produce a filtrate and flocculated solids. The method may further comprise adding the coagulant into a stream of effluent flowing within a first conduit under controlled shear conditions, and adding the flocculant into a stream of effluent containing pin flocs flowing within a second conduit under controlled shear conditions. The method may further comprise delivering the effluent containing the suspended flocs into a filter through a conduit floating in the effluent contained in the filter. | 11-08-2012 |
20140144844 | METHOD AND APPARATUS FOR TREATING NATURAL GAS AND OIL WELL DRILLING WASTE WATER - A method of treating contaminated water effluent from a well drilling operation. The method comprises decomposing organic contaminants in the effluent by bubbling a gas containing ozone through the effluent; adding a coagulant to increase the particle size of solid particles contained in the effluent; adding a flocculant to increase the particle size of solid particles contained in the effluent, thereby forming floes suspended in the effluent; and filtering the floes from the effluent to produce a filtrate and flocculated solids. The method may further comprise adding the coagulant into a stream of effluent flowing within a first conduit under controlled shear conditions, and adding the flocculant into a stream of effluent containing pin floes flowing within a second conduit under controlled shear conditions. The method may further comprise delivering the effluent containing the suspended floes into a filter through a conduit floating in the effluent contained in the filter. | 05-29-2014 |
20150218020 | METHOD AND APPARATUS FOR TREATING FRACTURE WATER FOR REMOVAL OF CONTAMINANTS AT A WELLHEAD - A method and apparatus for removing the barium and strontium salts in water that flows back to the well head after hydrofracturing in gas well drilling. Trace levels of iron salts may also be removed from the waste frac water, followed by removal of the calcium and magnesium salts, where applicable. The barium and strontium salts are precipitated in the inert sulfate form, which renders the resulting solids mass suitable for conventional landfill or on-site disposal, and more significantly, for potential reuse and as an additive to certain well drilling processes. The calcium and magnesium salts are similarly inert and suitable for conventional disposal. The process may be managed to selectively remove barium and strontium salts to desired levels, depending upon the intended reuse or disposition. The apparatus may be provided in a highly compact portable configuration that is transportable by a highway vehicle. | 08-06-2015 |
Patent application number | Description | Published |
20100226973 | METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND USES THEREOF - The present invention relates to liposomal vaccine compositions, methods for the manufacture thereof, and methods for the use thereof to stimulate an immune response in an animal. These compositions comprise dimyristoylphosphatidylcholine (“DMPC”); either dimyristoylphosphatidylglycerol (“DMPG”) or dimyristoyltrimethylammonium propane (“DMTAP”) or both DMPC and DMTAP; and at least one sterol derivative providing a covalent anchor for one or more immunogenic polypeptide(s) or carbohydrate(s). | 09-09-2010 |
20110177156 | Sterol-Modified Amphiphilic Lipids - Disclosed are sterol-modified amphiphilic lipid compounds having two or more hydrophobic tails of which at least one is a sterol. Also disclosed are the processes for the synthesis of these compounds, compositions comprising such compounds, and the use of such compounds in delivery of an agent of interest, e.g., therapeutics, imaging agents, contrast materials for ultrasound applications, vaccines, biosensors, nutritional supplements and skin care products. | 07-21-2011 |
20130216607 | ZWITTERIONIC LIPIDS - In various embodiments, the present invention provides zwitterionic lipids, encapsulants incorporating these zwitterionic lipids and such encapsulants encapsulating one or more bioactive agent. An exemplary bioactive agent is a nucleic acid. Also provided are pharmaceutical formulations of the encapsulants and methods of using such formulations to deliver a bioactive agent to a subject in treating or diagnosing disease in that subject. | 08-22-2013 |
20140220110 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES - The present invention provides liposome compositions containing sparingly soluble drugs that are used to treat life-threatening diseases. A preferred method of encapsulating a drug inside a liposome is by remote or active loading. Remote loading of a drug into liposomes containing a transmembrane electrochemical gradient is initiated by co-mixing a liposome suspension with a solution of drug, whereby the neutral form of the compound freely enters the liposome and becomes electrostatically charged thereby preventing the reverse transfer out of the liposome. There is a continuous build-up of compound within the liposome interior until the electrochemical gradient is dissipated or all the drug is encapsulated in the liposome. However, this process as described in the literature has been limited to drugs that are freely soluble in aqueous solution or solubilized as a water-soluble complex. This invention describes compositions and methods for remote loading drugs with low water solubility (<2 mg/mL). In the preferred embodiment the drug in the solubilizing agent is mixed with the liposomes in aqueous suspension so that the concentration of solubilizing agent is lowered to below its capacity to completely solubilize the drug. This results in the drug precipitating but remote loading capability is retained. The process is scalable and, in liposomes in which the lipid composition and remote loading agent are optimized, the resulting drug-loaded liposomes are characterized by a high drug-to-lipid ratios and prolonged drug retention when the liposome encapsulated drug is administered to a subject. | 08-07-2014 |
20140220111 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES - The present invention provides liposome compositions containing sparingly soluble drugs that are used to treat life-threatening diseases. A preferred method of encapsulating a drug inside a liposome is by remote or active loading. Remote loading of a drug into liposomes containing a transmembrane electrochemical gradient is initiated by co-mixing a liposome suspension with a solution of drug, whereby the neutral form of the compound freely enters the liposome and becomes electrostatically charged thereby preventing the reverse transfer out of the liposome. There is a continuous build-up of compound within the liposome interior until the electrochemical gradient is dissipated or all the drug is encapsulated in the liposome. However, this process as described in the literature has been limited to drugs that are freely soluble in aqueous solution or solubilized as a water-soluble complex. This invention describes compositions and methods for remote loading drugs with low water solubility (<2 mg/mL). In the preferred embodiment the drug in the solubilizing agent is mixed with the liposomes in aqueous suspension so that the concentration of solubilizing agent is lowered to below its capacity to completely solubilize the drug. This results in the drug precipitating but remote loading capability is retained. The process is scalable and, in liposomes in which the lipid composition and remote loading agent are optimized, the resulting drug-loaded liposomes are characterized by a high drug-to-lipid ratios and prolonged drug retention when the liposome encapsulated drug is administered to a subject. | 08-07-2014 |
20140220112 | TRANSFORMATION OF DRUG CYCLODEXTRIN COMPLEX COMPOSITIONS INTO COMPOSITIONS OF MIXTURES OF LIPID VESICLE ENCAPSULATED DRUG AND CYCLODEXTRIN DRUG COMPLEXES - Sparingly water-soluble agents can be formulated as cyclodextrin complexes, however, these water-soluble drug-cyclodextrin complexes dissociate when the complex is administered into patients. The dilution of the complex in the patient leads to the drug being released from the complex, so the drug is not effectively targeted. In contrast, drugs encapsulated in the aqueous core of a lipid vesicles are not released when the liposome is diluted in blood. This invention describes compositions and methods whereby cyclodextrin or polyanionic beta-cyclodextrin drug-complexes are mixed with a preformed liposome containing the amine salts of an acidic compound. This results in the drug cyclodextrin complex being transferred into the liposome where it is stably retained. The liposome-encapsulated drug can then be injected into a patient. | 08-07-2014 |
20140271825 | PHARMACEUTICAL FORMULATIONS OF CHELATING AGENTS AS A METAL REMOVAL TREATMENT SYSTEM - The present invention provides liposomes loaded with chelating agents, pharmaceutical formulations including these liposomes and methods of making chelating agent liposomes. Because the chelating agents are loaded in the liposome with high efficiencies, the liposomes are of use in treatment of metal ion overload in subjects. The liposomes can include two or more different chelating agents of different structures and affinities for metal ions. | 09-18-2014 |
20140308341 | METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND USES THEREOF - The present invention relates to liposomal vaccine compositions, methods for the manufacture thereof, and methods for the use thereof to stimulate an immune response in an animal. These compositions comprise dimyristoylphosphatidylcholine (“DMPC”); either dimyristoylphosphatidylglycerol (“DMPG”) or dimyristoyltrimethylammonium propane (“DMTAP”) or both DMPC and DMTAP; and at least one sterol derivative providing a covalent anchor for one or more immunogenic polypeptide(s) or carbohydrate(s). | 10-16-2014 |